Hepatitis C Virus (HCV) is a major public health problem worldwide. While highly efficacious directly-acting antiviral agents have been developed in recent years, their high costs and relative inaccessibility make their use limited. In this thesis, new uracil-based compounds have been evaluated as potential antiviral drugs against HCV. Using several biochemical and virological assays to investigate virus infection and replication, it has been shown that these compounds are able to significantly reduce viral genomic replication with their IC50 values in the nanomolar range. Finally, these compounds have been shown to block the de novo RNA synthesis and that effect is dependent on a chemical structure of the compounds.
Exploration of new uracil-based compounds as novel inhibitors of Hepatitis C Virus replication / Magri, Andrea. - ELETTRONICO. - (2016). [10.20373/uniupo/openthesis/115181]
Exploration of new uracil-based compounds as novel inhibitors of Hepatitis C Virus replication
MAGRI, ANDREA
2016-01-01
Abstract
Hepatitis C Virus (HCV) is a major public health problem worldwide. While highly efficacious directly-acting antiviral agents have been developed in recent years, their high costs and relative inaccessibility make their use limited. In this thesis, new uracil-based compounds have been evaluated as potential antiviral drugs against HCV. Using several biochemical and virological assays to investigate virus infection and replication, it has been shown that these compounds are able to significantly reduce viral genomic replication with their IC50 values in the nanomolar range. Finally, these compounds have been shown to block the de novo RNA synthesis and that effect is dependent on a chemical structure of the compounds.File | Dimensione | Formato | |
---|---|---|---|
PDF A. Magri tesi di dottorato.pdf
file ad accesso aperto
Descrizione: PDF A. Magri tesi di dottorato
Tipologia:
Altro materiale allegato
Licenza:
DRM non definito
Dimensione
4.41 MB
Formato
Adobe PDF
|
4.41 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.